Angioedema clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor
Sorry, not currently recruiting here
The purpose of this study is to evaluate the long-term safety and efficacy of repeated subcutaneous (SC) administration of lanadelumab in adolescents and adults with non-histaminergic angioedema with normal C1-inhibitor who completed study SHP643-303 (NCT04206605).
at UCSD
Our lead scientists for Angioedema research studies include Alexander Kim.